Impairment of liver GH receptor signaling by fasting

被引:69
作者
Beauloye, V
Willems, B
de Coninck, V
Frank, SJ
Edery, M
Thissen, JP
机构
[1] UCL, DIAB 5474, Unite Diabetol & Nutr, B-1200 Brussels, Belgium
[2] Fac Med Necker Enfants Malad, INSERM, Unite Endocrinol Mol, U 344, F-75730 Paris, France
[3] Univ Alabama, Dept Cell Biol, Birmingham, AL 35294 USA
关键词
D O I
10.1210/en.143.3.792
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Fasting causes a state of GH resistance responsible for low circulating IGF-I levels. To investigate whether this resistance may result from alterations in the GH signaling path. way, we determined the effects of fasting on the GH transduction pathway in rat liver. Forty-eight-hour fasted or fed male rats were injected with recombinant rat GH via the portal vein. Liver was removed 0 and 15 min after injection. Although GH stimulated Janus kinase 2 (JAK2) phosphorylation in all animals, this was severely blunted in fasted animals. Similarly, the phosphorylation of the GH receptor, although observed in both fasted and fed rats after GH injection, was markedly reduced in fasted rats. A rapid signal transducer and activator of transcription 5 (STAT5) tyrosine phosphorylation was also induced in the liver of fed animals in response to GH. In contrast, in fasted rats only a slight phosphorylated STAT5 signal was observed. The inhibitory effect of fasting on these GH signaling molecules occurred without changes in their protein content. Furthermore, the impairment of the JAR-STAT pathway in fasted animals was associated with increased liver suppressor of cytokine signaling 3 mRNA levels. Although glucocorticoids, which are increased by fasting, may cause GH resistance, adrenalectomy failed to prevent alterations in the JAK-STAT pathway caused by fasting. In conclusion, the GH resistance induced by fasting is associated with impairment of the JAR-STAT signaling pathway. This might contribute to the decrease in liver IGF-I production observed in fasting.
引用
收藏
页码:792 / 800
页数:9
相关论文
共 51 条
  • [1] ABRAHAM GE, 1997, HDB RADIOIMMUNOASSAY, P591
  • [2] Growth hormone preferentially induces the rapid, transient expression of SOCS-3, a novel inhibitor of cytokine receptor signaling
    Adams, TE
    Hansen, JA
    Starr, R
    Nicola, NA
    Hilton, DJ
    Billestrup, N
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (03) : 1285 - 1287
  • [3] Mechanism of signaling by growth hormone receptor
    Argetsinger, LS
    CarterSu, C
    [J]. PHYSIOLOGICAL REVIEWS, 1996, 76 (04) : 1089 - 1107
  • [4] THE EFFECT OF FASTING ON LIVER RECEPTORS FOR PROLACTIN AND GROWTH-HORMONE
    BAXTER, RC
    BRYSON, JM
    TURTLE, JR
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1981, 30 (11): : 1086 - 1090
  • [5] Dexamethasone inhibits both growth hormone (GH)-induction of insulin-like growth factor-I (IGF-I) mRNA and GH receptor (GHR) mRNA levels in rat primary cultured hepatocytes
    Beauloye, V
    Ketelslegers, JM
    Moreau, B
    Thissen, JP
    [J]. GROWTH HORMONE & IGF RESEARCH, 1999, 9 (03) : 205 - 211
  • [6] Identification of SOCS-3 as a potential mediator of central leptin resistance
    Bjorbaek, C
    Elmquist, JK
    Frantz, JD
    Shoelson, SE
    Flier, JS
    [J]. MOLECULAR CELL, 1998, 1 (04) : 619 - 625
  • [7] SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION
    CHOMCZYNSKI, P
    SACCHI, N
    [J]. ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) : 156 - 159
  • [8] Growth hormone stimulates tyrosine phosphorylation of JAK2 and STAT5, but not insulin receptor substrate-1 or SHC proteins in liver and skeletal muscle of normal rats in vivo
    Chow, JC
    Ling, PR
    Qu, ZS
    Laviola, L
    Ciccarone, A
    Bistrian, BR
    Smith, RJ
    [J]. ENDOCRINOLOGY, 1996, 137 (07) : 2880 - 2886
  • [9] Potentiation of growth hormone-induced liver suppressors of cytokine signaling messenger ribonucleic acid by cytokines
    Colson, A
    Le Cam, A
    Maiter, D
    Edery, M
    Thissen, JP
    [J]. ENDOCRINOLOGY, 2000, 141 (10) : 3687 - 3695
  • [10] STAT5b is required for GH-induced liver Igf-I gene expression
    Davey, HW
    Xie, T
    McLachlan, MJ
    Wilkins, RJ
    Waxman, DJ
    Grattan, DR
    [J]. ENDOCRINOLOGY, 2001, 142 (09) : 3836 - 3841